Krka, d. d. (LJSE:KRKG)

Market Cap	6.52B
Revenue (ttm)	2.01B
Net Income (ttm)	398.80M
Shares Out	30.46M
EPS (ttm)	13.02
PE Ratio	16.43
Forward PE	16.65
Dividend	8.25 (3.86%)
Ex-Dividend Date	Jul 22, 2025

Volume	2,183
Average Volume	4,355
Open	213.00
Previous Close	213.00
Day's Range	213.00 - 215.00
52-Week Range	139.00 - 225.00
Beta	0.42
RSI	65.39
Earnings Date	Jan 29, 2026

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription prod...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 11,308
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: KRKG

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.